Publications by authors named "Sandro Manni"

Claim this Profile
C
Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemic.
Anouschka Akerman, Christina Fichter, Vanessa Milogiannakis, Camille Esneau, Mariana Ruiz Silva, Sandro Manni

EBioMedicine· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level.
Anouschka Akerman, Vanessa Milogiannakis, Tyra Jean, Camille Esneau, Mariana Ruiz Silva, Sandro Manni

EBioMedicine· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern.
Anupriya Aggarwal, Anouschka Akerman, Vanessa Milogiannakis, Mariana Ruiz Silva, Gregory Walker, Sandro Manni

EBioMedicine· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgG3 and IgM Identified as Key to SARS-CoV-2 Neutralization in Convalescent Plasma Pools.
Christina Kober, Sandro Manni, Svenja Wolff, Thomas Barnes, Shatanik Mukherjee

PLoS One· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling the concentration of anti-SARS-CoV-2 immunoglobulin G in intravenous immunoglobulin product batches.
Sara Stinca, Thomas W Barnes, Peter Vogel, Wilfried Meyers, Johannes Schulte-Pelkum, Sandro Manni

PLoS One· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of neutralising anti-SARS-CoV-2 antibody half-life in COVID-19 convalescent donors.
Thomas W Barnes, Johannes Schulte-Pelkum, Laura Steller, Daniel Filchtinski, Robin Jenness, Sandro Manni

Clin Immunol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional and structural characterization of the kinase insert and the carboxy terminal domain in VEGF receptor 2 activation.
Sandro Manni, Kaisa Kisko, Thomas Schleier, Jack Missimer, Kurt Ballmer-Hofer

FASEB J· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural and functional characterization of alternative transmembrane domain conformations in VEGF receptor 2 activation.
Sandro Manni, Konstantin S Mineev, Dinara Usmanova, Ekaterina N Lyukmanova, Mikhail A Shulepko

Structure· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis